Allurion Technologies Inc. (ALUR)

Market Cap	11.22M
Revenue (ttm)	19.92M
Net Income (ttm)	-30.66M
Shares Out	7.76M
EPS (ttm)	-7.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,712
Open	1.500
Previous Close	1.500
Day's Range	1.410 - 1.500
52-Week Range	1.350 - 17.500
Beta	-0.50
Analysts	Buy
Price Target	9.25 (+540.14%)
Earnings Date	Nov 12, 2025

About ALUR

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company operates in Spain, France, Turkey, and internationally. Allurion Technologies In...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 137
• Stock Exchange: NYSE
• Ticker Symbol: ALUR
• Website: https://www.allurion.com

Financial Performance

In 2024, Allurion Technologies's revenue was $32.11 million, a decrease of -39.94% compared to the previous year's $53.47 million. Losses were -$26.15 million, -68.23% less than in 2023.

Analyst Summary

According to 2 analysts, the average rating for ALUR stock is "Buy." The 12-month stock price target is $9.25, which is an increase of 540.14% from the latest price.

Price Target

$9.25

(540.14% upside)

Analyst Consensus: Buy